FDA — authorised 25 July 1997
- Application: NDA020726
- Marketing authorisation holder: NOVARTIS PHARMS
- Local brand name: FEMARA
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Femara in United States
FDA authorised Femara on 25 July 1997
Marketing authorisation
Other Oncology approved in United States
Frequently asked questions
Is Femara approved in United States?
Yes. FDA authorised it on 25 July 1997.
Who is the marketing authorisation holder for Femara in United States?
NOVARTIS PHARMS holds the US marketing authorisation.